1. EXTH-81. ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA. (14th November 2022) Authors: Bakhshinyan, David; Suk, Yujin; Kuhlman, Laura; Adile, Ashley; Ignatchenko, Vladimir; Gwynne, William; Custers, Stefan; Macklin, Andrew; Venugopal, Chitra; Kislinger, Thomas; Singh, Sheila Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE. Issue 2 (22nd June 2018) Authors: Kameda-Smith, Michelle; Wang, Alick; Abdulhadi, Noora; Adile, Ashley; Ajani, Olufemi; Yarascavitch, Blake; Farrokhyar, Forough; Tina, Petrelli; Samaan, Constantine; Alyman, Cheryl; Singh, Sheila; Fleming, Adam Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA. (4th December 2020) Authors: Kameda-Smith, Michelle; Zhu, Helen; Luo, EnChing; Venugopal, Chitra; Xella, Agata; Brown, Kevin; Fox, Raymond; Yee, Brian; Xing, Sansi; Tan, Frederick; Bakhshinyan, David; Adile, Ashley; Subapanditha, Minomi; Picard, Daniel; Moffat, Jason; Fleming, Adam; Hope, Kristin; John, Provias; Remke, Marc;... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA. Issue 2 (22nd June 2018) Authors: Kameda-Smith, Michelle; Venugopal, Chitra; Bakhshinyan, David; Manoranjan, Branavan; Adile, Ashley; Subapanditha, Minomi; Fleming, Adam; Hope, Kristen; Singh, Sheila Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MEDU-10. THERAPEUTIC TARGETING OF STEM CELL SELF-RENEWAL IN CHILDHOOD MEDULLOBLASTOMA: STRATEGIES FOR BLOCKING RECURRENCE. (23rd April 2019) Authors: Bakhshinyan, David; Kameda-Smith, Michelle; Adile, Ashley; Manoranjan, Branavan; Venugopal, Chitra; Singh, Sheila Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA. (23rd April 2019) Authors: Kameda-Smith, Michelle; Brown, Kevin; Zhu, Helen; Luo, EnChing; Yee, Brian; Xing, Sansi; Venugopal, Chitra; Nostrand, Eric van; Bakhshinyan, David; Subapanditha, Minomi; Adile, Ashley; Provias, John; Fleming, Adam; Hope, Kristin; Reimand, Juri; Lu, Yu; Yeo, Gene; Wechsler-Reya, Robert; Singh, Sheila Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THER-14. SMALL MOLECULE INHIBITOR TARGETING SELF-RENEWAL AS A THERAPEUTIC OPTION FOR RECURRENT MEDULLOBLASTOMA. (23rd April 2019) Authors: Adile, Ashley; Bakhshinyan, David; Venugopal, Chitra; Subapanditha, Minomi; Weetall, Marla; Davis, Thomas; Singh, Sheila Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗